Phathom Pharmaceuticals, Inc. (PHAT)
NASDAQ: PHAT · IEX Real-Time Price · USD
11.08
-0.73 (-6.18%)
At close: Jun 21, 2024, 4:00 PM
11.07
-0.01 (-0.09%)
After-hours: Jun 21, 2024, 6:18 PM EDT

Phathom Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Year
Current20232022202120202019 2018
Market Capitalization
649523467618962764
Upgrade
Market Cap Growth
-11.93%-24.43%-35.78%25.98%-
Upgrade
Enterprise Value
776577518526724544
Upgrade
PE Ratio
-2.52-2.59-2.36-4.29-7.45-2.99
Upgrade
PS Ratio
250.03766.45----
Upgrade
PB Ratio
-4.18-7.18-6.248.564.953.35
Upgrade
P/FCF Ratio
-3.69-3.75-3.16-4.15-13.60-20.84
Upgrade
P/OCF Ratio
-3.72-3.80-3.19-4.16-13.81-20.92
Upgrade
EV/Sales Ratio
299.17846.49----
Upgrade
EV/EBITDA Ratio
-3.82-3.63-3.05-3.85-5.83-2.17
Upgrade
EV/EBIT Ratio
-3.81-3.62-3.04-3.84-5.81-2.17
Upgrade
EV/FCF Ratio
-4.45-4.15-3.51-3.53-10.23-14.83
Upgrade
Debt / Equity Ratio
-3.05-6.03-2.761.270.250.10
Upgrade
Debt / EBITDA Ratio
-2.31-2.76-1.22-0.67-0.39-0.09
Upgrade
Debt / FCF Ratio
-2.69-3.15-1.40-0.61-0.69-0.64
Upgrade
Quick Ratio
7.579.955.949.695.1865.04
Upgrade
Current Ratio
7.8310.256.129.865.2568.20
Upgrade
Asset Turnover
0.010.000000
Upgrade
Interest Coverage
-3.94-3.80-6.24-20.20-27.17-60.08
Upgrade
Return on Equity (ROE)
445.50%494.30%1126.60%-121.90%-69.00%-225.10%
Upgrade
Return on Assets (ROA)
-77.50%-76.10%-108.40%-65.50%-49.50%-197.70%
Upgrade
Return on Capital (ROIC)
-68.14%-45.70%-130.85%-82.62%-51.65%-42.23%
Upgrade
Earnings Yield
-38.03%-38.57%-42.34%-23.28%-13.41%-33.40%
Upgrade
FCF Yield
-25.96%-26.63%-31.60%-24.08%-7.35%-4.80%
Upgrade
Buyback Yield / Dilution
-37.82%-31.11%-5.72%-11.36%-192.32%-87.83%
Upgrade
Total Shareholder Return
-37.82%-31.11%-5.72%-11.36%-192.32%-87.83%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).